◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › PLSM

Pulsenmore Ltd. (PLSM) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-09

Pulsenmore Ltd. (PLSM) operates in the Medical Devices industry and is headquartered in Omer, Israel with about 71 employees. Its market capitalization is roughly $27 million. In the fiscal year ended 2025-12-31, PLSM reported $40M in revenue and ($16M) in net income.

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.

Interactive charts & full statements →

PLSM Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$40M$10M$6M$11M
Gross Profit$34M$4M$2M$5M
Operating Income (EBIT)($12M)($42M)($56M)($46M)
Net Income($16M)($37M)($59M)($22M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PLSM Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid$0M$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PLSM Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$102M$142M$180M$236M
Total Liabilities$19M$45M$48M$49M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PLSM viewer.

Other Companies in Medical Devices

← PLSEAll stocksPLTK →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.